Latest News

December 7

Policymaker Action Required to Ensure Patient Access to Lung Cancer Treatments

Advances in treatment have completely transformed the way that Americans are living with lung cancer, something that was unthinkable even ten years ag...

December 7

Site-Neutral Payments Are Less Than Meets the Eye, Experts Say

The new "site-neutral payment" policy of the Centers for Medicare & Medicaid Services (CMS) will hurt hospitals less than they claim and help inde...

December 7

MedPAC Mulls Scrapping ‘Incident To’ Billing for NPs, PAs

What's known as "incident to" billing for nurse practitioners and physician assistants in Medicare could vanish if the government adopts a recommendat...

December 7

Azar Names New Drug Pricing Advisor Following Predecessor’s Death

Pharmacist and veteran drug policy expert John O'Brien has been named Senior Advisor to the Secretary for Drug Pricing Reform, Health and Human Servic...

December 7

CMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 2020

On November 26, 2018, the Centers for Medicare & Medicaid Services (“CMS”) issued a proposed rule titled “Modernizing Part D and Medicare Advantag...

December 7

Don’t Let the Trump Administration Corporatize Medicare

The Trump administration is engaged in a massive deception about Medicare Advantage plans, those commercial insurance plans that contract with the gov...

Read more

Home 2018-11-27T11:53:18+00:00


COA supports a wide variety of initiatives for community oncology practices, professionals, and patient advocates. We give community
oncologists and hematologists a powerful voice to help drive policymaking, innovation, and reform of the cancer care system.